Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Contraception
  5. Back
  6. Diaphragms and Caps
  7. User Acceptability, Drug Interactions, Assessment of Client Suitability, Examination
Update your RDS mobile app to v4.7.2 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience  arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

User Acceptability, Drug Interactions, Assessment of Client Suitability, Examination

Warning

Variable and discontinuation rates can be high.

Advantages

  • non hormonal
  • no serious side effects
  • use is under the user’s control
  • silicone is suitable for clients or sexual partners with latex allergy or latex sensitivity
  • only need to be inserted prior to intercourse and retained for 6 hours afterwards
  • Caya ® and Femcap® are available to purchase over the counter or on line. They come with illustrated fitting instructions.  

Perceived disadvantages

  • messiness
  • problems with insertion / removal
  • irritation from spermicide
  • lack of sexual spontaneity
  • patients should initially be assessed for type and correct size of Singa diaphragm by a trained health professional. Size may need changed after pregnancy
  • No good evidence of protection against HIV/STI or CIN. As only the cervix is covered by these methods, they do not prevent exposure of the vaginal mucosa to semen or exposure of the penis to cervico-vaginal secretions.

Drug interactions

Silicone diaphragms/caps are unaffected by oil-based lubricants but the manufacturer of Caya® and Singa® advises only water based lubricants should be used.

Assessment of client suitability (excluding Caya)

In this context the history should include: relevant social and sexual history (to assess risk of sexually transmitted infections – STIs), the importance attached to avoiding pregnancy and willingness to insert the device.

Prolapse, small or absent retropubic recess The diaphragm may not fit adequately with a prolapse or small /absent retropubic recess but a cap is suitable. Caya’s manufacturer states Caya cannot be used with severe pelvic floor or uterine descent.

Caya’s manufacturer does not recommend its use in people who previously used a diaphragm size of 85mm and larger, or 60mm and smaller.

Acute frequent bladder infections Diaphragm use has been linked to urinary tract infection. A diaphragm should be chosen that will ensure a correct fit but which does not put undue pressure on or obstruct the urethra.

Toxic Shock Syndrome The CEU Clinical Effectiveness Unit consider menstruation a contraindication to diaphragm use. The manufacturer of the Caya® diaphragm report it is safe to use during menstruation

Postpartum use

Manufacturer advice re earliest post partum fitting

  • Caya and Singa: 6 weeks
  • Femcap: 10 weeks

There is no evidence that nonoxynol-9 is teratogenic. Its use in lactation has not been
studied.

Examination

Pelvic examination is required to identify the appropriate size and type of Singa®
diaphragm
Caya® is one-size. Femcap size is based on parity
Clients may wish help ensuring they have fitted the device correctly

Editorial Information

Last reviewed: 31/03/2022

Next review date: 30/09/2025

Author(s): West of Scotland Managed Clinical Network for Sexual Health Guidelines Group.

Version: 6.1

Approved By: West of Scotland Managed Clinical Network for Sexual Health